CreditReports.dk
HomeScreen companies

NORDIC BIOTECH K/S Financials, key figures and credit report

CVR number: 26290724 Established 2001 Industry: 64 Financial service activities, except insurance and pension funding
Company contact details
Strandvejen 125, 2900 Hellerup
Gross profit - 157.0 kDKK FY 2024 -18% vs 2023
EBIT - 157.0 kDKK FY 2024 -18% vs 2023
Net debt - 504.0 kDKK FY 2024 +93% vs 2023
Quick ratio 6.6 FY 2024 -69.9 vs 2023

Company information

Official name
NORDIC BIOTECH K/S
Established
2001
Company form
Limited partnership
Industry

Data sources and methodology

The information about NORDIC BIOTECH K/S combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2024.

Open the 2024 annual report

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About NORDIC BIOTECH K/S

NORDIC BIOTECH K/S (CVR number: 2629072-4) is a company from KØBENHAVN. The company recorded a gross profit of -157 kDKK in 2024. The operating profit was -157 kDKK, while net earnings were 101.5 mDKK. The profitability of the company measured by Return on Assets (ROA) was 127.3 %, which can be considered excellent and Return on Equity (ROE) was 127.4 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 99.9 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. NORDIC BIOTECH K/S's liquidity measured by quick ratio was 6.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.

Financial information

See financials

Gross profit (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
2020
2021
2022
2023
2024
Volume
Net sales
Gross profit-98.00- 119.00- 118.00- 133.00- 157.00
EBIT-1 354.00-6 381.00- 118.00- 133.00- 157.00
Net earnings-1 360.00-6 387.00-44 572.001 254.00101 458.00
Shareholders equity total85 109.0078 722.0034 150.0032 232.00127 032.00
Balance sheet total (assets)85 170.0078 784.0034 208.0032 326.00127 129.00
Net debt- 858.00- 734.00- 606.00-7 190.00- 504.00
Profitability
EBIT-%
ROA-1.6 %-7.8 %-78.9 %3.8 %127.3 %
ROE-1.6 %-7.8 %-79.0 %3.8 %127.4 %
ROI-1.6 %-7.8 %-79.0 %3.8 %127.4 %
Economic value added (EVA)-5 699.07-10 657.73-4 073.78-1 849.04-1 776.66
Solvency
Equity ratio99.9 %99.9 %99.8 %99.7 %99.9 %
Gearing
Relative net indebtedness %
Liquidity
Quick ratio14.111.810.476.56.6
Current ratio14.111.810.476.56.6
Cash and cash equivalents858.00734.00606.007 190.00504.00
Capital use efficiency
Trade debtors turnover (days)
Net working capital %

Variable visualization

ROA FY 2024
127.3%
Rating 100/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2024
99.9%
Rating 99/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of NORDIC BIOTECH K/S before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
€3 / report

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Companies in the same industry

Page generated